Skip to content

Memory Enhancement in Aging With Optimal Dosing

Personalized Memory Enhancement in Aging: Pattern-Optimized tACS With Closed-Loop Precision Modulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07461584
Enrollment
240
Registered
2026-03-10
Start date
2026-06-01
Completion date
2031-01-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Memory, Noninvasive Brain Stimulation

Brief summary

This project optimizes high-resolution transcranial Alternating Current Stimulation (tACS) to improve memory in healthy older adults, advancing drug-free approaches for Alzheimer's disease and related dementia (ADRD). We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.

Detailed description

Cognitive decline, especially in memory and executive control, poses an escalating public health challenge as the population ages, contributing to loss of independence, reduced quality of life, and increased healthcare costs associated with Alzheimer's disease and related dementias (ADRD). Despite decades of research, there are few effective, non-pharmacological interventions capable of slowing or reversing these cognitive losses. Transcranial alternating current stimulation (tACS) has recently emerged as a promising, safe, and non-invasive technique for modulating neural rhythms that support memory. However, existing approaches remain limited by one-size-fits-all stimulation schedules that fail to account for individual brain connectivity patterns or dynamic fluctuations in cognitive state. This project aims to advance precision neuromodulation for cognitive aging by optimizing and personalizing high-resolution tACS protocols to enhance memory in older adults. Building on strong pilot data demonstrating the feasibility of personalized and adaptive stimulation, we will use multimodal imaging (EEG and fMRI) to track changes in frontotemporal synchrony, specifically theta-gamma phase-amplitude coupling and theta phase synchronization, that are known to support memory formation and retrieval. Aim 1 will establish how stimulation pattern (patterned vs. continuous waveforms) and schedule (one, three, or five consecutive days) shape the durability of memory enhancement. By comparing six systematically varied dosing protocols, we will determine the optimal pattern and repetition schedule that maximize and sustain improvements in working memory capacity, interference control, and long-term memory recognition over one month. By integrating behavioral, electrophysiological, and neuroimaging measures with adaptive control algorithms, this research will identify reliable biomarkers of responsiveness, elucidate causal mechanisms linking neural synchrony to memory, and yield a new class of personalized, connectivity-guided interventions for cognitive decline. The findings will lay a foundation for scalable, non-invasive, and mechanism-driven treatments for ADRD and age-related memory loss, advancing the broader NIH mission of promoting healthy cognitive aging.

Interventions

DEVICE1-day patterned tACS

Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.

DEVICE3-day patterned tACS

Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.

DEVICE5-day patterned tACS

Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.

DEVICE1-day continuous tACS

Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.

DEVICE3-day continuous tACS

Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.

DEVICE5-day continuous tACS

Device: High definition transcranial electrical current stimulation Low-intensity, noninvasive application of electrical current to the human scalp with the goal of modulating levels of neuronal excitability.

Sponsors

Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 65 years of age or older * normal or corrected-to-normal vision * color vision

Exclusion criteria

* pregnant * metal implants in head * implanted electronic devices * history of neurological problems or head injury * skin sensitivity * claustrophobia * dementia (normal Montreal Cognitive Assessment \> 25) * depression (normal Geriatric Depression Scale \< 10) * history of psychosis * cognitive deficits (MoCA\>25) * any psychoactive medication

Design outcomes

Primary

MeasureTime frameDescription
Visual working memory capacity measured behaviorallyBaseline, 1-week after intervention, 1-month after interventionBehavioral k-capacity estimate derived from the change-detection task
Interruption suppression measured behaviorallyBaseline, 1-week after intervention, 1-month after interventionMemory accuracy performance difference between interruption and control trials on the interruption working memory task
EEG phase locking value (PLV) during working memory retentionBaseline, 1-week after intervention, 1-month after interventionPhase locking value between frontotemporal EEG electrodes within the theta frequency band during the memory retention interval of the visual working memory task
EEG phase amplitude coupling (PAC) during working memory retentionBaseline, 1-week after intervention, 1-month after interventionTheta phase gamma amplitude cross-frequency coupling at temporal EEG electrodes during the memory retention interval of the visual working memory task

Countries

United States

Contacts

CONTACTRobert Reinhart, PhD
rmgr@bu.edu(617) 353-9481
PRINCIPAL_INVESTIGATORRobert Reinhart, PhD

Boston University Charles River Campus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026